Diagnostic accuracy of cerebrospinal fluid pleocytosis in suspected meningoencephalomyelitis of unknown origin in canines

Published:

2026-11-16

Share
Open Access Logo

DOI

https://doi.org/10.18849/ve.v11i4.759

Abstract

PICO Question

In canines with suspected meningoencephalomyelitis of unknown origin (MUO) [population], does cerebrospinal fluid analysis for pleocytosis [intervention], compared with histopathology [comparison], accurately identify underlying noninfectious inflammatory central nervous system (CNS) disease [outcome]?

 

Clinical bottom line

Category of research

Diagnosis.

Number and type of study designs reviewed

Three retrospective case series and one systematic review.

Strength of evidence

Moderate.

Outcomes reported

The four studies included collectively reported the presence or absence of cerebrospinal fluid (CSF) pleocytosis in dogs with histopathologically confirmed noninfectious inflammatory CNS disease or clinically diagnosed MUO where applicable. Pleocytosis is defined as a total nucleated cell count (TNCC) above the laboratory reference interval. The first study reported pleocytosis in all 22 dogs evaluated with granulomatous meningoencephalomyelitis (GME). In contrast, the second paper identified normal TNCC in a substantial proportion of GME cases, a finding mirrored by the third study across a significant number of GME, necrotising meningoencephalitis (NME), and clinically diagnosed MUO patients. Finally, the fourth study documented normal repeat CSF TNCC levels in a single dog with progressive NME within a small sample size.

Conclusion

Cerebrospinal fluid pleocytosis supports a diagnosis of noninfectious inflammatory CNS disease in dogs with suspected MUO but does not exclude disease when absent. Furthermore, CSF findings cannot reliably distinguish between inflammatory disease subtypes. Therefore, CSF analysis should be interpreted alongside neurological examination, magnetic resonance imaging (MRI) findings, and exclusion of infectious diseases rather than used as a standalone diagnostic test.

References

Andersen-Ranberg, E., Berendt, M. & Gredal, H. (2021). Biomarkers of non-infectious inflammatory CNS diseases in dogs — Where are we now? Part I: Meningoencephalitis of unknown origin. The Veterinary Journal. 273, 105678. DOI: https://doi.org/10.1016/j.tvjl.2021.105678

Bailey, C.S. & Higgins, R.J. (1986). Characteristics of cerebrospinal fluid associated with canine granulomatous meningoencephalomyelitis: A retrospective study. Journal of the American Veterinary Medical Association. 188(4), 418–421. DOI: https://doi.org/10.2460/javma.1986.188.04.418

Coates, J.R. & Jeffery, N.D. (2014). Perspectives on Meningoencephalomyelitis of Unknown Origin. Veterinary Clinics of North America: Small Animal Practice. 44(6), 1157–1185. DOI: https://doi.org/10.1016/j.cvsm.2014.07.009 

Cornelis, I., Volk, H.A. & De Decker, S. (2016). Clinical presentation, diagnostic findings and long-term survival in large breed dogs with meningoencephalitis of unknown aetiology. Veterinary Record. 179(6), 147. DOI: https://doi.org/10.1136/vr.103640 

Danciu, C.G., Szladovits, B., Crawford, A.H., Ognean, L. & De Decker, S. (2021). Cerebrospinal fluid analysis lacks diagnostic specificity in dogs with vestibular disease. Veterinary Record. 189(10), e557. DOI: https://doi.org/10.1002/vetr.557 

Demierre, S., Vandevelde, M., Jaggy, A., Griot-Wenk, M.E., Welle, M. & Tipold, A. (2001). Correlation between the clinical course of granulomatous meningoencephalomyelitis in dogs and the extent of mast cell infiltration. The Veterinary Record. 148(15), 467–472. DOI: https://doi.org/10.1136/vr.148.15.467

Granger, N., Smith, P.M. & Jeffery, N.D. (2010). Clinical findings and treatment of non-infectious meningoencephalomyelitis in dogs: A systematic review of 457 published cases from 1962 to 2008. The Veterinary Journal. 184(3), 290–297. DOI: https://doi.org/10.1016/j.tvjl.2009.03.031

Lampe, R., Foss, K.D., Vitale, S., Hague, D.W. & Barger, A. M. (2020). Comparison of cerebellomedullary and lumbar cerebrospinal fluid analysis in dogs with neurological disease. Journal of Veterinary Internal Medicine. 34(2), 838–843. DOI: https://doi.org/10.1111/jvim.15700

Lowrie, M., Smith, P.M. & Garosi, L. (2013). Meningoencephalitis of unknown origin: investigation of prognostic factors and outcome using a standard treatment protocol. Veterinary Record. 172(20), 527. DOI: https://doi.org/10.1136/vr.101431 

Stalis, I.H., Chadwick, B. Dayrell-Hart, B., Summers, B.A. & Van Winkle, T.J. (1995). Necrotizing Meningoencephalitis of Maltese Dogs. Veterinary Pathology. 32(3), 230–235. DOI: https://doi.org/10.1177/030098589503200303

Tipold, A. (1995). Diagnosis of Inflammatory and Infectious Diseases of the Central Nervous System in Dogs: A Retrospective Study. Journal of Veterinary Internal Medicine. 9(5), 304–314. DOI: https://doi.org/10.1111/j.1939-1676.1995.tb01089.x